Edgewell Personal Care Company (EPC) 10-Year Financial Performance & Capital Metrics

EPC • • Industrial / General

Consumer DefensiveHousehold ProductsPersonal Care & CosmeticsSkincare & Hair Care

AboutEdgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet shave, Sun and Skin care, and Feminine care. The Wet Shave segment provides razor systems, such as razor handles and refillable blades, and disposable shave products for men and women under the Schick, Wilkinson Sword, Edge, Skintimate, Shave Guard, and Personna brands. The Sun and Skin Care segment provides general protection, sport, kids, baby, tanning and after sun products under the Banana Boat and Hawaiian Tropic brands, as well as antibacterial hand wipes, alcohol sanitizing wipes, and hand sanitizer gels under the Wet Ones brand; and skin care products for men under the Bulldog and Jack Black brands, and skin care and grooming products under the Cremo brand. The Feminine Care segment provides tampons under the Playtex Gentle Glide 360°, Playtex Sport, Playtex and o.b. brands; and markets pads and liners under the Stayfree and Carefree brands. The company was formerly known as Energizer Holdings, Inc. and changed its name to Edgewell Personal Care Company in June 2015. Edgewell Personal Care Company was founded in 1772 and is headquartered in Shelton, Connecticut.Show more

Revenue $2.25B
EBITDA $287M -9.8%
Net Income $99M -14.0%
EPS (Diluted) 1.97 -10.9%
Gross Margin 42.41% +1.5%
EBITDA Margin 12.75% -9.9%
Operating Margin 8.84% -12.3%
Net Margin 4.38% -14.1%
ROE 6.31% -17.3%
ROIC 5.4% -12.6%
Debt/Equity 0.87 -6.9%
Interest Coverage 2.61 -9.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 3.3%
✓Share count reduced 3.3% through buybacks
✓Trading at only 0.6x book value

✗Weaknesses

✗Weak momentum: RS Rating 17 (bottom 17%)
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-6.57%

5Y1.03%

3Y2.59%

TTM-2.92%

Profit (Net Income) CAGR

10Y-12.05%

5Y-

3Y-5.76%

TTM-46.49%

EPS CAGR

10Y-10.06%

5Y-

3Y-2.42%

TTM-126.35%

ROCE

10Y Avg7.03%

5Y Avg6.59%

3Y Avg6.37%

Latest6.24%

Peer Comparison

Skincare & Hair Care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AXILAXIL Brands, Inc.	52.99M	7.79	77.90	-4.51%	3.26%	8.85%	2.9%	0.08
ULUnilever PLC	141.09B	64.70	28.25	1.94%	10.16%	61.19%	5.51%	1.36
CLColgate-Palmolive Company	66.87B	82.96	23.64	3.31%	14.47%	234.81%	5.3%	15.65
PGThe Procter & Gamble Company	337.05B	144.24	22.16	0.29%	19.74%	31.31%	4.17%	0.68
SLSNSolesence, Inc. Common Stock	107.22M	1.52	21.71	40.35%	1.72%	6.21%		1.02
EPCEdgewell Personal Care Company	861.43M	18.44	9.36	0.09%	2.94%	4.13%	20.26%	0.87
UGUnited-Guardian, Inc.	28.76M	6.26	8.82	11.91%	19.48%	18.52%	10.55%

Profit & Loss

	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Sales/Revenue+	2.42B	2.36B	2.3B	2.23B	2.14B	1.95B	2.09B	2.17B	2.25B	2.25B
Revenue Growth %	-0.46%	-0.02%	-0.03%	-0.03%	-0.04%	-0.09%	0.07%	0.04%	0.04%	0%
Cost of Goods Sold+	1.24B	1.2B	1.17B	1.2B	1.17B	1.07B	1.14B	1.29B	1.31B	1.3B
COGS % of Revenue	0.51%	0.51%	0.51%	0.54%	0.55%	0.55%	0.54%	0.59%	0.58%	0.58%
Gross Profit+	1.18B	1.16B	1.13B	1.03B	966.6M	880.9M	951.2M	880.5M	940.8M	955.7M
Gross Margin %	0.49%	0.49%	0.49%	0.46%	0.45%	0.45%	0.46%	0.41%	0.42%	0.42%
Gross Profit Growth %	-0.08%	-0.02%	-0.03%	-0.08%	-0.06%	-0.09%	0.08%	-0.07%	0.07%	0.02%
Operating Expenses+	1.18B	1.16B	1.13B	1.03B	722.8M	704.9M	711.3M	698.2M	713.8M	756.4M
OpEx % of Revenue	0.49%	0.49%	0.49%	0.46%	0.34%	0.36%	0.34%	0.32%	0.32%	0.34%
Selling, General & Admin	938.7M	749.4M	710.8M	688.4M	622.9M	625M	632.7M	627.4M	638.7M	662.1M
SG&A % of Revenue	0.39%	0.32%	0.31%	0.31%	0.29%	0.32%	0.3%	0.29%	0.28%	0.29%
Research & Development	71M	71.9M	67.6M	61.1M	53.5M	55.3M	57.8M	55.5M	58.5M	58.4M
R&D % of Revenue	0.03%	0.03%	0.03%	0.03%	0.02%	0.03%	0.03%	0.03%	0.03%	0.03%
Other Operating Expenses	174.1M	338.6M	347.5M	283.4M	46.4M	24.6M	20.8M	15.3M	16.6M	35.9M
Operating Income+	174.1M	338.6M	347.5M	283.4M	243.8M	176M	239.9M	182.3M	227M	199.3M
Operating Margin %	0.07%	0.14%	0.15%	0.13%	0.11%	0.09%	0.11%	0.08%	0.1%	0.09%
Operating Income Growth %	-0.45%	0.94%	0.03%	-0.18%	-0.14%	-0.28%	0.36%	-0.24%	0.25%	-0.12%
EBITDA+	289.4M	431.2M	441.9M	381M	337.6M	264.8M	327M	272.2M	318.4M	287.3M
EBITDA Margin %	0.12%	0.18%	0.19%	0.17%	0.16%	0.14%	0.16%	0.13%	0.14%	0.13%
EBITDA Growth %	-0.36%	0.49%	0.02%	-0.14%	-0.11%	-0.22%	0.23%	-0.17%	0.17%	-0.1%
D&A (Non-Cash Add-back)	115.3M	92.6M	94.4M	97.6M	93.8M	88.8M	87.1M	89.9M	91.4M	88M
EBIT	-358.9M	291.7M	16.3M	231.8M	-327.7M	148.5M	215M	195.5M	226.2M	197.4M
Net Interest Income+	-99.8M	-71.8M	-69.2M	-68M	-62.6M	-61.2M	-67.9M	-71.4M	-78.5M	-76.5M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	99.8M	71.8M	69.2M	68M	62.6M	61.2M	67.9M	71.4M	78.5M	76.5M
Other Income/Expense	-632.8M	-118.7M	-400.4M	-119.6M	-634.1M	-88.7M	-92.8M	-58.2M	-79.3M	-78.4M
Pretax Income+	-458.7M	219.9M	-52.9M	163.8M	-390.3M	87.3M	147.1M	124.1M	147.7M	120.9M
Pretax Margin %	-0.19%	0.09%	-0.02%	0.07%	-0.18%	0.04%	0.07%	0.06%	0.07%	0.05%
Income Tax+	-162.6M	41.2M	-58.6M	60.5M	-18.1M	19.7M	29.3M	24.6M	33M	22.3M
Effective Tax Rate %	0.6%	0.81%	-0.11%	0.63%	0.95%	0.77%	0.8%	0.8%	0.78%	0.82%
Net Income+	-275.3M	178.7M	5.7M	103.3M	-372.2M	67.6M	117.8M	99.5M	114.7M	98.6M
Net Margin %	-0.11%	0.08%	0%	0.05%	-0.17%	0.03%	0.06%	0.05%	0.05%	0.04%
Net Income Growth %	-1.77%	1.65%	-0.97%	17.12%	-4.6%	1.18%	0.74%	-0.16%	0.15%	-0.14%
Net Income (Continuing)	-296.1M	178.7M	5.7M	103.3M	-372.2M	67.6M	117.8M	99.5M	114.7M	98.6M
Discontinued Operations	20.8M	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-4.44	2.99	0.10	1.90	-6.52	1.24	2.12	1.86	2.21	1.97
EPS Growth %	-1.78%	1.67%	-0.97%	18%	-4.43%	1.19%	0.71%	-0.12%	0.19%	-0.11%
EPS (Basic)	-4.44	3.02	0.10	1.90	-6.52	1.25	2.15	1.87	2.24	1.98
Diluted Shares Outstanding	62M	59.7M	57.5M	54.5M	54.1M	54.6M	55.2M	53.6M	51.8M	50.1M
Basic Shares Outstanding	61.95M	59.2M	57.3M	54.4M	54.1M	54.3M	54.4M	53.1M	51.2M	49.7M
Dividend Payout Ratio	-	-	-	-	-	-	0.22%	0.33%	0.27%	0.31%

Balance Sheet

	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Total Current Assets+	1.64B	1.45B	1.19B	951.2M	1.04B	983.6M	1.14B	942.2M	962.4M	936M
Cash & Short-Term Investments	712.1M	738.9M	502.9M	266.4M	341.6M	364.7M	479.2M	188.7M	216.4M	209.1M
Cash Only	712.1M	738.9M	502.9M	266.4M	341.6M	364.7M	479.2M	188.7M	216.4M	209.1M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	434.3M	289.8M	241M	239.1M	205.6M	229.8M	230.6M	208.9M	168.8M	164.1M
Days Sales Outstanding	65.47	44.78	38.27	39.06	35.05	43.02	40.32	35.11	27.36	26.58
Inventory	332.8M	309.2M	333.5M	329.5M	357.2M	314.1M	345.7M	449.3M	492.4M	477.3M
Days Inventory Outstanding	98.17	93.88	103.82	100.1	111.02	107.27	111.06	127.01	137.11	134.22
Other Current Assets	100.5M	94.2M	70.1M	60.4M	75M	10.2M	12.9M	25.1M	12.3M	9.1M
Total Non-Current Assets+	3.36B	3.32B	3B	3B	2.4B	2.56B	2.54B	2.77B	2.78B	2.79B
Property, Plant & Equipment	476.1M	486.1M	453.4M	424.1M	396M	414.4M	362.6M	345.5M	337.9M	434.5M
Fixed Asset Turnover	5.09x	4.86x	5.07x	5.27x	5.41x	4.70x	5.76x	6.29x	6.66x	5.19x
Goodwill	1.42B	1.42B	1.45B	1.45B	1.05B	1.16B	1.16B	1.32B	1.33B	1.34B
Intangible Assets	1.41B	1.39B	1.07B	1.1B	912.9M	928.1M	906.4M	996.7M	973.8M	948.5M
Long-Term Investments	-335.8M	-255.3M	-181.8M	-176.1M	-101.1M	0	0	0	0	0
Other Non-Current Assets	48.7M	28M	31.6M	28.2M	34.8M	55.1M	107.1M	106.6M	135.2M	73.3M
Total Assets+	4.99B	4.77B	4.19B	3.95B	3.44B	3.54B	3.67B	3.71B	3.74B	3.73B
Asset Turnover	0.49x	0.50x	0.55x	0.57x	0.62x	0.55x	0.57x	0.58x	0.60x	0.60x
Asset Growth %	-0.28%	-0.04%	-0.12%	-0.06%	-0.13%	0.03%	0.04%	0.01%	0.01%	-0%
Total Current Liabilities+	666.8M	868.2M	524.4M	717M	659.6M	510.5M	536.8M	539.5M	523.4M	563.6M
Accounts Payable	236.9M	196.5M	223.6M	238.4M	222.8M	181.9M	209.5M	228.8M	194.4M	219.3M
Days Payables Outstanding	69.88	59.66	69.61	72.42	69.25	62.12	67.31	64.68	54.13	61.67
Short-Term Debt	17.5M	300.3M	19.4M	193.1M	131.4M	30.2M	26.5M	19M	19.5M	41.2M
Deferred Revenue (Current)	1000K	0	0	1000K	1000K	1000K	600K	1000K	0	1000K
Other Current Liabilities	365.6M	269.6M	222.5M	214.7M	230.3M	215.1M	132.4M	122.3M	131.9M	209.8M
Current Ratio	2.45x	1.67x	2.26x	1.33x	1.58x	1.93x	2.12x	1.75x	1.84x	1.66x
Quick Ratio	1.96x	1.32x	1.63x	0.87x	1.04x	1.31x	1.47x	0.91x	0.90x	0.81x
Cash Conversion Cycle	93.76	79	72.48	66.73	76.82	88.17	84.08	97.44	110.34	99.13
Total Non-Current Liabilities+	2.46B	2.07B	1.92B	1.49B	1.46B	1.6B	1.55B	1.71B	1.68B	1.58B
Long-Term Debt	1.7B	1.54B	1.53B	1.1B	1.1B	1.24B	1.23B	1.39B	1.36B	1.27B
Capital Lease Obligations	0	0	0	0	0	34.6M	46.9M	41.5M	53.9M	69.8M
Deferred Tax Liabilities	335.8M	255.3M	181.8M	176.1M	102.8M	124.3M	129M	140.4M	136.4M	149.8M
Other Non-Current Liabilities	421M	274.8M	397.3M	387.9M	360M	200.7M	143.4M	133.2M	125.8M	88.6M
Total Liabilities	3.13B	2.94B	2.45B	2.21B	2.12B	2.11B	2.09B	2.25B	2.2B	2.15B
Total Debt+	1.72B	1.84B	1.54B	1.3B	1.23B	1.3B	1.32B	1.46B	1.45B	1.39B
Net Debt	1.01B	1.11B	1.04B	1.03B	887.6M	938M	839.4M	1.27B	1.23B	1.18B
Debt / Equity	0.92x	1.01x	0.89x	0.74x	0.93x	0.91x	0.83x	1.00x	0.94x	0.87x
Debt / EBITDA	5.95x	4.28x	3.50x	3.40x	3.64x	4.92x	4.03x	5.37x	4.55x	4.82x
Net Debt / EBITDA	3.49x	2.56x	2.36x	2.70x	2.63x	3.54x	2.57x	4.67x	3.87x	4.10x
Interest Coverage	1.74x	4.72x	5.02x	4.17x	3.89x	2.88x	3.53x	2.55x	2.89x	2.61x
Total Equity+	1.86B	1.83B	1.74B	1.74B	1.32B	1.43B	1.58B	1.47B	1.54B	1.58B
Equity Growth %	-0.26%	-0.02%	-0.05%	0%	-0.24%	0.08%	0.11%	-0.07%	0.05%	0.03%
Book Value per Share	30.07	30.64	30.29	32.01	24.45	26.24	28.70	27.37	29.74	31.62
Total Shareholders' Equity	1.86B	1.83B	1.74B	1.74B	1.32B	1.43B	1.58B	1.47B	1.54B	1.58B
Common Stock	700K	700K	700K	700K	700K	700K	700K	700K	700K	700K
Retained Earnings	772.9M	946M	952.9M	1.08B	734.1M	782.4M	865.7M	939.1M	1.02B	1.09B
Treasury Stock	-382.2M	-563M	-703.9M	-819.2M	-803.8M	-790.4M	-776.3M	-860.9M	-906.1M	-937.9M
Accumulated OCI	-171.5M	-197.2M	-131.4M	-148.3M	-235.9M	-191.6M	-136.9M	-216.1M	-170M	-154.8M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Cash from Operations+	148.8M	176.4M	296.2M	264.7M	190.6M	232.6M	229M	102M	216.1M	231M
Operating CF Margin %	0.06%	0.07%	0.13%	0.12%	0.09%	0.12%	0.11%	0.05%	0.1%	0.1%
Operating CF Growth %	-0.74%	0.19%	0.68%	-0.11%	-0.28%	0.22%	-0.02%	-0.55%	1.12%	0.07%
Net Income	-275.3M	178.7M	5.7M	103.3M	-352.9M	67.6M	117.8M	99.5M	114.7M	98.6M
Depreciation & Amortization	115.3M	92.6M	94.4M	97.6M	93.8M	88.8M	87.1M	89.9M	91.4M	88M
Stock-Based Compensation	33.1M	25.6M	22.2M	17M	17.8M	19.2M	27.3M	23.8M	27.5M	26.5M
Deferred Taxes	-190.4M	7.8M	-87.4M	2.3M	-57.9M	-2.9M	9.6M	-13.7M	-4.5M	-9.6M
Other Non-Cash Items	23M	-109.8M	282M	43.4M	537.3M	16.7M	15.2M	-15.4M	-18M	-20.1M
Working Capital Changes	13.5M	-18.5M	-20.7M	1.1M	-47.5M	43.2M	-28M	-82.1M	5M	47.6M
Change in Receivables	21.7M	23.3M	41.4M	-5.4M	-1.9M	66.3M	3.7M	-6.6M	31M	-7.3M
Change in Inventory	-35.7M	28.2M	-15.5M	-12.3M	-35M	37.1M	-28.8M	-111.3M	-32.4M	19.7M
Change in Payables	-73.4M	-29.3M	23.7M	11.5M	-15.1M	-42.9M	24.3M	29.3M	-30.2M	17M
Cash from Investing+	-174.8M	-69.5M	-84.6M	-128.5M	-45.5M	-196.4M	-48.7M	-355.4M	-50.5M	-62.4M
Capital Expenditures	-99.4M	-69.5M	-69M	-62M	-58M	-47.7M	-56.8M	-56.4M	-49.5M	-56.5M
CapEx % of Revenue	0.04%	0.03%	0.03%	0.03%	0.03%	0.02%	0.03%	0.03%	0.02%	0.03%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-63.3M	0	18.4M	4.7M	8.4M	2.9M	900K	5.4M	-1M	-5.9M
Cash from Financing+	-327.2M	-83M	-460.6M	-375.2M	-63.8M	-18.7M	-65.4M	-17.6M	-146.5M	-179.4M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-93.2M	0	0	0	0	0	-25.6M	-32.6M	-31.5M	-30.7M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-510.4M	9.8M	-200K	-7.5M	5.4M	-28.5M	-8.7M	-10.8M	-6.8M	-6.4M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	49.4M	106.9M	227.2M	202.7M	132.6M	184.9M	172.2M	45.6M	166.6M	174.5M
FCF Margin %	0.02%	0.05%	0.1%	0.09%	0.06%	0.09%	0.08%	0.02%	0.07%	0.08%
FCF Growth %	-0.9%	1.16%	1.13%	-0.11%	-0.35%	0.39%	-0.07%	-0.74%	2.65%	0.05%
FCF per Share	0.80	1.79	3.95	3.72	2.45	3.39	3.12	0.85	3.22	3.48
FCF Conversion (FCF/Net Income)	-0.54x	0.99x	51.96x	2.56x	-0.51x	3.44x	1.94x	1.03x	1.88x	2.34x
Interest Paid	164.3M	71.3M	66.4M	66.6M	60.6M	56.1M	61M	68.4M	74.3M	62.8M
Taxes Paid	55M	28.3M	14.4M	22M	58M	24.6M	25.4M	23.8M	45.8M	33.5M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-12.55%	9.68%	0.32%	5.93%	-24.27%	4.91%	7.81%	6.52%	7.63%	6.31%
Return on Invested Capital (ROIC)	3.98%	8.74%	9.12%	7.65%	7.34%	5.76%	7.51%	5.3%	6.18%	5.4%
Gross Margin	48.89%	49.11%	48.99%	46.23%	45.15%	45.18%	45.57%	40.54%	41.78%	42.41%
Net Margin	-11.37%	7.57%	0.25%	4.62%	-17.38%	3.47%	5.64%	4.58%	5.09%	4.38%
Debt / Equity	0.92x	1.01x	0.89x	0.74x	0.93x	0.91x	0.83x	1.00x	0.94x	0.87x
Interest Coverage	1.74x	4.72x	5.02x	4.17x	3.89x	2.88x	3.53x	2.55x	2.89x	2.61x
FCF Conversion	-0.54x	0.99x	51.96x	2.56x	-0.51x	3.44x	1.94x	1.03x	1.88x	2.34x
Revenue Growth	-45.56%	-2.45%	-2.69%	-2.78%	-4.18%	-8.94%	7.06%	4.04%	3.68%	0.09%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Razors and blades	1.28B	1.26B	1.22B	1.19B	1.11B	1.02B	1.08B	1.11B	1.1B	1.11B
Razors and blades Growth	-	-1.46%	-2.98%	-3.00%	-6.50%	-7.68%	5.99%	2.23%	-0.47%	0.67%
Sun care products	320.1M	337.7M	351.6M	342M	328.7M	283.3M	333.6M	401.8M	450.7M	483.6M
Sun care products Growth	-	5.50%	4.12%	-2.73%	-3.89%	-13.81%	17.76%	20.44%	12.17%	7.30%
Tampons, Pads and Liners	398.2M	388.9M	353.1M	329.4M	308.1M	298.6M	286.1M	290.7M	315.2M	283.6M
Tampons, Pads and Liners Growth	-	-2.34%	-9.21%	-6.71%	-6.47%	-3.08%	-4.19%	1.61%	8.43%	-10.03%
Infant Care and Other Products	-	-	153.3M	125.2M	123M	26.8M	-	-	172.5M	182.9M
Infant Care and Other Products Growth	-	-	-	-18.33%	-1.76%	-78.21%	-	-	-	6.03%
Shaving gels and creams	-	-	131.1M	144.7M	141.7M	139M	131.3M	133.7M	127.3M	118.3M
Shaving gels and creams Growth	-	-	-	10.37%	-2.07%	-1.91%	-5.54%	1.83%	-4.79%	-7.07%
Skin Care Products	83.5M	77.2M	87.3M	107.7M	131.1M	178.7M	251.7M	236.7M	82.3M	74.3M
Skin Care Products Growth	-	-7.54%	13.08%	23.37%	21.73%	36.31%	40.85%	-5.96%	-65.23%	-9.72%
Shave Prep	163.1M	166.3M	-	-	-	-	-	-	-	-
Shave Prep Growth	-	1.96%	-	-	-	-	-	-	-	-
Infant Care and Other	178.1M	132.4M	-	-	-	-	-	-	-	-
Infant Care and Other Growth	-	-25.66%	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	1.4B	1.39B	1.33B	1.25B	1.19B	1.08B	1.18B	1.31B	1.33B	1.26B
UNITED STATES Growth	-	-0.83%	-4.42%	-6.37%	-4.54%	-8.95%	9.31%	10.38%	1.50%	-4.85%
Non-US	1.02B	970M	967.9M	988.6M	951.8M	866.9M	903.7M	865.2M	925.5M	991.9M
Non-US Growth	-	-4.68%	-0.22%	2.14%	-3.72%	-8.92%	4.25%	-4.26%	6.97%	7.17%

Frequently Asked Questions

Valuation & Price

Edgewell Personal Care Company (EPC) has a price-to-earnings (P/E) ratio of 9.4x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Edgewell Personal Care Company (EPC) reported $2.20B in revenue for fiscal year 2024. This represents a 53% decrease from $4.65B in 2011.

Edgewell Personal Care Company (EPC) grew revenue by 0.1% over the past year. Growth has been modest.

Yes, Edgewell Personal Care Company (EPC) is profitable, generating $64.8M in net income for fiscal year 2024 (4.4% net margin).

Dividend & Returns

Yes, Edgewell Personal Care Company (EPC) pays a dividend with a yield of 3.32%. This makes it attractive for income-focused investors.

Edgewell Personal Care Company (EPC) has a return on equity (ROE) of 6.3%. This is below average, suggesting room for improvement.

Edgewell Personal Care Company (EPC) generated $42.7M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...